Evidence map›Paper›PMID 24824985›Full record

ArticleAmerican journal of epidemiology2014

Medication use in pregnancy in relation to the risk of isolated clubfoot in offspring.

Martha M Werler, Mahsa M Yazdy, James R Kasser, Susan T Mahan, Robert E Meyer, Marlene Anderka, Charlotte M Druschel, Allen A Mitchell

Open access · bronzeAbstract read
In one paragraph

Article in American journal of epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. A Scoping Review of 5-HTPharmacoepidemiology and drug safety · 2026
    Article
  5. Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  6. Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis.European journal of obstetrics & gynecology and reproductive biology: X · 2021
    Review
  7. Integrated Bioinformatics Analysis Reveals Potential Pathway Biomarkers and Their Interactions for Clubfoot.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Martha M Werler
Mahsa M Yazdy
James R Kasser
Susan T Mahan
Robert E Meyer
Marlene Anderka
Charlotte M Druschel
Allen A Mitchell
Boston University · US

Funding

Maternal Vasoactive Exposures and Risk of ClubfootR01HD051804 · NICHD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WERLER, MARTHA M. · 2006 to 2010
$2.8M
NICHD NIH HHS R01 HD051804NICHD NIH HHS R01-HD051804
6 · The paper itself

Abstract

Clubfoot, a common major structural malformation, develops early in gestation. Epidemiologic studies have identified higher risks among boys, first-born children, and babies with a family history of clubfoot, but studies of risks associated with maternal exposures are lacking. We conducted the first large-scale, population-based, case-control study of clubfoot with detailed information on maternal medication use in pregnancy. Study subjects were ascertained from birth defect registries in Massachusetts, New York, and North Carolina during 2007-2011. Cases were 646 mothers of children with clubfoot without other major structural malformations (i.e., isolated clubfoot); controls were mothers of 2,037 children born without major malformations. Mothers were interviewed within 12 months of delivery about medication use, including product, timing, and frequency. Odds ratios were estimated for exposure to 27 medications in pregnancy months 2-4 after adjustment for study site, infant sex, first-born status, body mass index (weight (kg)/height (m)(2)), and smoking. Odds ratios were less than 1.20 for 14 of the medications; of the remainder, most odds ratios were only slightly elevated (range, 1.21-1.66), with wide confidence intervals. The use of antiviral drugs was more common in clubfoot cases than in controls (odds ratio = 4.22, 95% confidence interval: 1.52, 11.73). Most of these results are new findings and require confirmation in other studies.

Indexed as

AdultCase-Control StudiesClubfootDrug-Related Side Effects and Adverse ReactionsFemaleHumansMaleMassachusettsMaternal AgeNew YorkNorth CarolinaPregnancyPrenatal Exposure Delayed EffectsRegistriesRisk FactorsYoung Adultclubfootmalformationmedicationspregnancy

Identifiers

PMID24824985
PMCPMC4133556
OpenAlexW2111286338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.